tiprankstipranks
Cue Biopharma Inc (CUE)
NASDAQ:CUE
US Market
CUE
Cue Biopharma
RESEARCH TOOLSreports
Want to see CUE full AI Analyst Report?

Cue Biopharma (CUE) Income Statement

658 Followers

Cue Biopharma Income Statement

Last quarter (Q1 2026), Cue Biopharma's total revenue was $5.69M, an increase of 260.79% from the same quarter last year. In Q1, Cue Biopharma's net income was $-5.18M. See Cue Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Mar 24Dec 22Dec 21
Total Revenue
$ 27.47M$ 9.29M$ 5.49M$ 1.25M$ 14.94M
Gross Profit
$ 27.47M$ 9.29M$ -32.61M$ 1.25M$ 16.72M
Operating Expenses
$ 53.99M$ 50.79M$ 19.54M$ 54.47M$ 60.43M
Depreciation and Amortization
$ 3.48M$ 2.35M$ 3.44M$ 1.81M$ -1.78M
EBITDA
$ -22.27M$ -37.53M$ -46.05M$ -50.49M$ -45.44M
Operating Income
$ -26.52M$ -41.50M$ -52.15M$ -53.23M$ -43.71M
Other Income/Expenses
$ 419.00K$ 826.00K$ 1.42M$ 215.00K$ 45.90K
Pretax Income
$ -26.10M$ -40.67M$ -50.73M$ -53.01M$ -43.67M
Net Income
$ -26.60M$ -40.67M$ -50.73M$ -53.01M$ -44.16M
Per Share Metrics
Basic EPS
$ -8.40$ -21.60$ -33.30$ -44.70$ -42.30
Diluted EPS
$ -8.40$ -21.60$ -33.30$ -44.70$ -42.30
Weighted Average Shares Outstanding
 3.16M 1.88M 1.53M 1.19M 1.04M
Weighted Average Shares Outstanding (Diluted)
 3.16M 1.88M 1.53M 1.19M 1.04M
Currency in USD

Cue Biopharma Earnings and Revenue History